{"schema_version":"secwatch.filing_event.v1","accession":"0001860782-24-000060","form_type":"8-K","ticker":null,"cik":"0001860782","company_name":"2seventy bio, Inc.","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.945993+00:00","generated_at":"2026-06-03T08:15:24.628694+00:00","sec_items":["2.02"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"2seventy bio announces Q1 2024 Abecma U.S. revenue of $52M","bullets":["Abecma generated approximately $52M in U.S. Q1 2024 revenue, unaudited.","Company and BMS share equally in all profits and losses for Abecma in the U.S.","Full Q1 2024 results to be announced on or before May 15, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001860782-24-000060","json":"https://secwatch.observer/filing/0001860782-24-000060.json","markdown":"https://secwatch.observer/filing/0001860782-24-000060.md","text":"https://secwatch.observer/filing/0001860782-24-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860782/000186078224000060/0001860782-24-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860782/000186078224000060/tvst-20240425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T08:15:24.628694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5659e6eb00340c55ac2fe549f6645d077a654e16","claim":"2seventy bio, Inc. reported the first quarter of 2024 results: revenue $52 million.","evidence_excerpt":"On April 25, 2024, 2seventy bio, Inc. (the “Company”) announced that Abecma (idecabtagene vicleucel, or ide-cel) generated approximately $52 million in U.S. revenue during the first quarter of 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860782/000186078224000060/0001860782-24-000060-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2024"},{"label":"Revenue","value":"$52 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}